Integra Cytal Burn Matrix 10x15 cm: Endotoxin Risk in Medical Products
Integra LifeSciences recalls Cytal Burn Matrix 10x15 cm products with endotoxin out-of-specification results. Affected units include specific lot numbers and product IDs. Consumers should contact Integra for details.
Lower-risk recall
Increased rate of out-of-specification endotoxin results.
Contact the company
What happened, in plain English
Integra LifeSciences is recalling Cytal Burn Matrix 10x15 cm products due to increased endotoxin levels that could cause infections. This recall affects medical devices used in burn treatments. Read more at govinfonow.com/recall/49663-integra-cytal-burn-matrix-10x15-cm-endotoxin-risk-in-medical.
Source Summary by GovInfoNow · govinfonow.com/recall/49663-integra-cytal-burn-matrix-10x15-cm-endotoxin-risk-in-medical · Updated August 17, 2026 · FDA enforcement record: FDA #Z-1820-2026
Cite this page
“Integra Cytal Burn Matrix 10x15 cm: Endotoxin Risk in Medical Products.” GovInfoNow, updated August 17, 2026. https://govinfonow.com/recall/49663-integra-cytal-burn-matrix-10x15-cm-endotoxin-risk-in-medical. Based on FDA recall #Z-1820-2026 (https://api.fda.gov/device/enforcement.json?search=recall_number:%22Z-1820-2026%22&limit=1).
Why it’s dangerous
Endotoxins are bacterial components that can cause infections if they enter the body. Higher levels than specified in these products may lead to infections in burn patients.
Who’s affected
Medical professionals and patients using Cytal Burn Matrix 10x15 cm for burn treatment. Those with specific lot numbers or product IDs are most at risk.
How to tell if you have this one
Check for product ID BMM1015 on the packaging. Affected units include lot numbers 7579681, 7582225, 7582227, 7583933, 7591942, 7591944, 7583935, 7593018, 7594284, and 7593013.
- Brand
Integra LifeSciences- Category
Medical device
All 5 products in this recall
FDA lists each product line separately under one recall event. Check your product description, lot or code numbers against each row. Every row shares the hazard and remedy on this page.
- Classification
Class II- Status
Ongoing- Distribution
US Nationwide distribution in the states of AL, AZ, CA, DC, FL, GA, IA, IL, KS, KY, LA, MD, ME, MN, MO, MT, NC, ND, NE, NJ, NY, OH, PA, SC, SD, TN, TX, VA, VT, WA, WI, WV.
| Recall number | Product, codes & lots | Quantity |
|---|---|---|
| Z-1816-2026 | Cytal Wound Matrix 2-Layer 5x5 cm. Product ID: WSM0505.; Product ID: WSM0505. UDI-DI: 00386190001431. Lot Numbers: 7579683, 7583933, 7583891, 7583935, 7594266, 7594286, 7593011. | 148 units |
| Z-1817-2026 | Cytal Wound Matrix 2-Layer 7x10 cm. Product ID: WSM0710.; Product ID: WSM0710. UDI-DI: 00386190001448. Lot Numbers: 7579683, 7582225, 7583893, 7582227, 7583933, 7583891, 7591942, 7591944, 7583935, 7594266, 7594288, 7594286, 7593011, 7594284, 7593013. | 46 units |
| Z-1818-2026 | Cytal Wound Matrix 2-Layer 10x15 cm. Product ID: WSM1015.; Product ID: WSM1015. UDI-DI: 00386190001455. Lot Numbers: 7579681, 7582225, 7583893, 7582227, 7591942, 7591944, 7583935, 7594266, 7593018, 7594288, 7594284, 7593013. | 452 units |
| Z-1819-2026 | Cytal Burn Matrix 7x10 cm. Product ID: BMM0710.; Product ID: BMM0710. UDI-DI: 00386190001103. Lot Numbers: 7579683, 7579681, 7582227, 7583891, 7594266, 7593018, 7593011, 7593013. | 7 units |
| Z-1820-2026 | Cytal Burn Matrix 10x15 cm. Product ID: BMM1015.; Product ID: BMM1015. UDI-DI: 00386190001110. Lot Numbers: 7579681, 7582225, 7582227, 7583933, 7591942, 7591944, 7583935, 7593018, 7594284, 7593013. | 226 units |
What to do — step by step
Check Product Details
Look for product ID BMM1015 and affected lot numbers on the packaging.
Where it went and when
Where it was distributed
Distributed nationwide; the notice names 31 states.
FDA distribution: “US Nationwide distribution in the states of AL, AZ, CA, DC, FL, GA, IA, IL, KS, KY, LA, MD, ME, MN, MO, MT, NC, ND, NE, NJ, NY, OH, PA, SC, SD, TN, TX, VA, VT, WA, WI, WV.” States read from FDA’s own wording; “not listed” means the notice does not name it.
Named in the notice: Alabama, Arizona, California, District of Columbia, Florida, Georgia, Illinois, Iowa, Kansas, Kentucky, Louisiana, Maine, Maryland, Minnesota, Missouri, Montana, Nebraska, New Jersey, New York, North Carolina, North Dakota, Ohio, Pennsylvania, South Carolina, South Dakota, Tennessee, Texas, Vermont, Virginia, Washington, West Virginia, Wisconsin.
Recall timeline
FDA published this recall 34 days after the firm started it.
- Firm started the recall
- FDA classified it Class II
- Published in FDA’s Enforcement Report
Dates from the agency record only; steps without a date are left out.
Similar recalls
Latest medical device recalls
Keep exploring
Where this comes from
The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.
- Official source: FDA Recall #Z-1820-2026 (March 19, 2026) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for Z-1820-2026 to see it in context.
- Plain-language summary written by qwen3:4b on August 17, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
- GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.